Annexin Pharmaceuticals AB

NEW
FRA:Q910 (Sweden)  
€ 1.08 +0.0050 (+0.47%) Aug 7
At Loss
P/B:
6.59
Market Cap:
€ 8.27M ($ 9.56M)
Enterprise V:
€ 6.71M ($ 7.76M)
Volume:
0
Avg Vol (2M):
1.14K
Trade In:

Annexin Pharmaceuticals AB (FRA:Q910) Dividend

Annexin Pharmaceuticals AB (FRA:Q910) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -36.2%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: FRA:Q910 Dividend

Does Annexin Pharmaceuticals AB (FRA:Q910) pay a dividend?

Annexin Pharmaceuticals AB (FRA:Q910) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Annexin Pharmaceuticals AB pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Annexin Pharmaceuticals AB has returned capital to shareholders via buybacks at a rate of -36.2% over the past 3 years.

What are dividend-paying alternatives to Annexin Pharmaceuticals AB?

For dividend-paying alternatives in Annexin Pharmaceuticals AB's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.